A real‐world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple‐myeloma patients

Adult Aged, 80 and over Male 0301 basic medicine Middle Aged Dexamethasone Bortezomib 03 medical and health sciences Antineoplastic Combined Chemotherapy Protocols Panobinostat Humans Female Multiple Myeloma Aged Retrospective Studies
DOI: 10.1111/bjh.17076 Publication Date: 2020-12-04T08:21:40Z